Development of an abbreviated symptom score for the neonatal abstinence syndrome.
Publication/Presentation Date
7-1-2020
Abstract
OBJECTIVE: We sought a shortened MOTHER neonatal abstinence syndrome (NAS) and Finnegan score that would retain comparable performance characteristics of the full instrument.
STUDY DESIGN: Retrospective cohort.
RESULTS: In total, 124,170 MOTHER NAS scores between August 2007 and May 2016 from 775 infants (≥36 weeks) were examined. Classification and regression tree model identified the most important subsets of the scored variables. A 9-element shortened scale yielded >90% sensitivity and specificity to predict clinical endpoints based on the full 19-element MOTHER NAS score. Conversion of the data sets to the Finnegan score, and applying the same procedure resulted in a nine-element score with similar performance characteristics.
CONCLUSION: Shortened scoring instruments were identified with the high-predictive power for clinical endpoints based on the 19-element full MOTHER NAS score. There was no substantial variation in performance for age, supporting the current practice of utilizing a single scoring tool regardless of postnatal age.
Volume
40
Issue
7
First Page
1031
Last Page
1040
ISSN
1476-5543
Published In/Presented At
Chervoneva, I., Adeniyi-Jones, S. C., Blanco, F., & Kraft, W. K. (2020). Development of an abbreviated symptom score for the neonatal abstinence syndrome. Journal of perinatology : official journal of the California Perinatal Association, 40(7), 1031–1040. https://doi.org/10.1038/s41372-020-0606-4
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
32076111
Department(s)
Administration and Leadership
Document Type
Article